---
title: "Myriad Genetic | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 190.7 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294410315.md"
datetime: "2026-07-30T20:19:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294410315.md)
  - [en](https://longbridge.com/en/news/294410315.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294410315.md)
generator: "portal-rs"
---

# Myriad Genetic | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 190.7 M

Revenue: As of FY2026 Q2, the actual value is USD 190.7 M, missing the estimate of USD 206.03 M.

EPS: As of FY2026 Q2, the actual value is USD -0.46.

EBIT: As of FY2026 Q2, the actual value is USD -35.2 M.

The provided Form 8-K for Myriad Genetics, Inc. indicates that the company announced its financial results for the three months ended June 30, 2026, on July 30, 2026. However, the detailed financial results and forward-looking statements, which are contained in Exhibit 99.1, are not included in the provided reference text. Consequently, specific financial metrics such as segment revenue, net income, gross margin, operating profit, operating costs, operating cash flow, free cash flow, unique company-specific indicators, or any detailed outlook/guidance cannot be extracted from this document.

### Related Stocks

- [MYGN.US](https://longbridge.com/en/quote/MYGN.US.md)

## Related News & Research

- [Bill Ackman Loves This Dividend Stock, But You Should Give It a Pass](https://longbridge.com/en/news/296545633.md)
- [Live updates: Carney suspends trade talks with US, Freedom 250 Grand Prix begins in Washington](https://longbridge.com/en/news/296682816.md)
- [Elutia sells SimpliDerm business to Cellution Biologics for up to $11 million](https://longbridge.com/en/news/296653445.md)
- [Does scouting a lower gas price matter much? Plus, more August money questions](https://longbridge.com/en/news/296401607.md)
- [The creator economy's hottest debate: Can influencers post AI ads without alienating their fans?](https://longbridge.com/en/news/296515980.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**